Antimicrobial Resistance Interdisciplinary Research Group (AMR IRG)
A Singapore-MIT initiative
creating solutions to address AMR
The AMR IRG is a translational research and entrepreneurship program that tackles the growing threat of antimicrobial resistance.
By leveraging talent and convergent technologies across Singapore and MIT together, we aim to tackle AMR head-on by developing multiple innovative and disruptive approaches to identify, respond to, and treat drug-resistant microbial infections. Through strong scientific and clinical collaborations, our goal is to provide transformative, holistic solutions for Singapore and the world.
The AMR IRG is funded by the National Research Foundation Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) program.